Dedicated to NMR-based clinical screening and diagnostics, the AVANCE IVDR is optimized for ease-of-use and highest data quality and reliability.
The new standardized platform offers barcode analysis, control by a LIMS system, the high-throughput autosampler SampleJet™, remote access, and automatic analysis and customizable analytical result reporting. Based on Bruker-validated SOPs, the AVANCE IVDR platform enables the development of diagnostic tools for body-fluids that can address a variety of medical questions. The SOPs guarantee the production of highly reproducible clinical data, enabling the exchange and validation of novel NMR assays between laboratories on a global basis.
In a translational clinical research environment the results produced by these NMR assays can easily be transferred into clinical screening and future IVD use. This level of large-scale health-related NMR screening is paving the way for worldwide epidemiological studies as well as for clinical research and diagnosis. The benefits have been significant: facilitated by the low cost per sample and the even lower cost per parameter as compared to established single parameter screening methods, novel NMR methods for determining the cause of disease, delivering individualized patient treatment and developing strategies for prevention are now available to many clinical researchers.